Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy-Reference-Cited by-同舟云学术

Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy

Published:2024-06-19 Issue:3 Volume:11 Page:425-439
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Goldschmidt Jerome H.,Tseng Wan-Yu,Wang Yunfei,Espirito Janet,Vasudevan Anupama,Silver Michelle,Kwong Jackie,Shah Ruchit,Marrett Elizabeth

Funder

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40801-024-00440-3.pdf

Reference26 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

2. SEER*Explorer: an interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute. Data source(s): SEER incidence data, November 2022 submission (1975–2020), SEER 22 registries. April 19, 2023. Available from: https://seer.cancer.gov/statistics-network/explorer/. Accessed 26 Apr 2023.

3. Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol. 2021;7(12):1824–32.

4. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Non-small cell lung cancer version 3.2023. April 13, 2023. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 26 Apr 2023.

5. Tsao AS, Scagliotti GV, Bunn PA Jr, et al. Scientific advances in lung cancer 2015. J Thorac Oncol. 2016;11(5):613–38.